Results 261 to 270 of about 53,470 (300)
Some of the next articles are maybe not open access.
PharmacoEconomics, 2011
When going 'beyond the patient', to measure QALYs for unpaid carers, a number of additional methodological considerations and value judgements must be made. While there is no theoretical reason to restrict the measurement of QALYs to patients, decisions have to be made about which carers to consider, what instruments to use and how to aggregate and ...
Hareth, Al-Janabi +2 more
openaire +3 more sources
When going 'beyond the patient', to measure QALYs for unpaid carers, a number of additional methodological considerations and value judgements must be made. While there is no theoretical reason to restrict the measurement of QALYs to patients, decisions have to be made about which carers to consider, what instruments to use and how to aggregate and ...
Hareth, Al-Janabi +2 more
openaire +3 more sources
A QALY is a QALY is a QALY—or is it not?
2016This chapter looks at a theoretical framework for diversions from the assumption that all units of health gain have equal social value, and examins different ways in which welfarists and non-welfarists may call for cost per weighted QALY analyses, for efficiency-based reasons, and equity-motivated reasons.
John Brazier +3 more
openaire +1 more source
PharmacoEconomics, 2006
The QALY is the product of life expectancy (estimated in years) and its quality over that time (estimated in utilities or QOL units). It theoretically enables direct comparison of the costs of obtaining different health outcomes through cost utility analysis (CUA).
Maurice, McGregor, J Jaime, Caro
openaire +2 more sources
The QALY is the product of life expectancy (estimated in years) and its quality over that time (estimated in utilities or QOL units). It theoretically enables direct comparison of the costs of obtaining different health outcomes through cost utility analysis (CUA).
Maurice, McGregor, J Jaime, Caro
openaire +2 more sources
Bioethics, 1992
... We can therefore conclude that either we should go for equality; and in that case QALYs are unfair because they haven't got enough of an ageist bias. Or we should accept consequentialism; and in that case QALYs have just the right sort of ageist bias.
Sandøe, Peter, Kappel, Klemens
openaire +2 more sources
... We can therefore conclude that either we should go for equality; and in that case QALYs are unfair because they haven't got enough of an ageist bias. Or we should accept consequentialism; and in that case QALYs have just the right sort of ageist bias.
Sandøe, Peter, Kappel, Klemens
openaire +2 more sources
[QALYS or not QALYS: that is the question?].
Revue d'epidemiologie et de sante publique, 1996The article discusses the proposal of some health economists to use the "cost per QALY (quality-adjusted-life year)" ratio as an universal indicator for economic assessment of medical interventions, in the so-called "cost-utility" analyses. Authors argue that QALYs are not a straightforward application of expected utility theory, which is the standard ...
J P, Moatti +3 more
openaire +1 more source
Health Economics, 2003
Abstract A willingness to pay (WTP) per quality‐adjusted‐life year (QALY) of DKK 88 was estimated on the basis of elicited preferences for health states. The WTP per QALY estimate presented here differs considerably from that implied in contingent valuation studies, suggesting that WTP for reducing risk of death ...
openaire +7 more sources
Abstract A willingness to pay (WTP) per quality‐adjusted‐life year (QALY) of DKK 88 was estimated on the basis of elicited preferences for health states. The WTP per QALY estimate presented here differs considerably from that implied in contingent valuation studies, suggesting that WTP for reducing risk of death ...
openaire +7 more sources
Is a QALY still a QALY at the end of life?
Journal of Health Economics, 2012Recent research into end of life and palliative care has focused on the development of a replacement for the quality adjusted life year (QALY) as an outcome measure. Reasons given range from the lack of anticipated survival benefit from treatment to the inappropriateness of death as an anchor for valuing health states, or the increased value of time to
openaire +3 more sources
Health Economics, 2002
AbstractQuality‐adjusted life‐years (QALYs) calculated from time tradeoff (TTO) based preferences have a time preference component. To impose a conventional discount rate on these implicitly discounted QALYs introduces some degree of double discounting.
Linda D, MacKeigan +2 more
openaire +2 more sources
AbstractQuality‐adjusted life‐years (QALYs) calculated from time tradeoff (TTO) based preferences have a time preference component. To impose a conventional discount rate on these implicitly discounted QALYs introduces some degree of double discounting.
Linda D, MacKeigan +2 more
openaire +2 more sources
JAMA, 2011
THE QUALITY-ADJUSTED LIFE-YEAR (QALY) HAS COME under fire lately. In the United States, health reform legislation prohibited use of cost-per-QALY thresholds. The United Kingdom has proposed that the National Institute for Health and Clinical Excellence (NICE), which has influenced reimbursement through cost-per-QALY ratios, will not in the future use ...
openaire +2 more sources
THE QUALITY-ADJUSTED LIFE-YEAR (QALY) HAS COME under fire lately. In the United States, health reform legislation prohibited use of cost-per-QALY thresholds. The United Kingdom has proposed that the National Institute for Health and Clinical Excellence (NICE), which has influenced reimbursement through cost-per-QALY ratios, will not in the future use ...
openaire +2 more sources